AZ’s Nexium/aspirin combination gets EU thumbs-up

AstraZeneca have announced that Axanum, a fixed dose combination of 81 mg low-dose ASA (acetylsalicylic acid) and 20 mg esomeprazole, has received positive agreement for approval in 23 European Union member countries and in Norway. The combination is indicated for prevention of cardiovascular events such as heart attack or stroke, in high-risk patients in need of

Continue Reading